OBJECTIVE: The demand for eye-care services in the Netherlands is increasing. This article indicates the causes and attempts to provide an estimate of the increase between 2010 and 2020 and to indicate what will be the consequences. DESIGN: Descriptive study. METHOD: In the absence of data on the numbers of blind and visually impaired people in the Netherlands, we used data from the records of general practitioners, yearly statistics for the number of relevant activities in hospitals and a mathematical model to calculate the number of blind and visually impaired in the Netherlands. The data mentioned were extrapolated to the population of 2020. Additionally, the expected number of new treatments of neovascular age-related macular degeneration (AMD) and macular oedema in diabetic retinopathy and retinal venous occlusion were calculated by a model. RESULTS: The number of people over 65 in the Netherlands increases by 34% between 2010 and 2020. The registrations by general practitioners show an increase of 43% of patients with eye conditions. Modelling of the new treatment methods demonstrates a threefold increase of the number of treatments. Finally, it appears that the number of blind and visually impaired people increases by 20%. The prevalence of visual impairment is the highest in elderly in health-care institutions, mentally handicapped and elderly living independently. CONCLUSION: The demand for eye-care services will increase by 200-300% between 2010 and 2020. The most important cause for this is the new treatment for 'wet' AMD and macular oedema using intravitreal angiogenesis inhibitors. The capacity of eye care services needs to be increased, partly by a redistribution of tasks between different professional groups within the eye care sector. Routine vision screening of elderly in care institutions and people with a mental handicap can reduce the number of Dutch people with avoidable visual impairment. For elderly living independently, provision of information and selective screening is indicated.
OBJECTIVE: The demand for eye-care services in the Netherlands is increasing. This article indicates the causes and attempts to provide an estimate of the increase between 2010 and 2020 and to indicate what will be the consequences. DESIGN: Descriptive study. METHOD: In the absence of data on the numbers of blind and visually impaired people in the Netherlands, we used data from the records of general practitioners, yearly statistics for the number of relevant activities in hospitals and a mathematical model to calculate the number of blind and visually impaired in the Netherlands. The data mentioned were extrapolated to the population of 2020. Additionally, the expected number of new treatments of neovascular age-related macular degeneration (AMD) and macular oedema in diabetic retinopathy and retinal venous occlusion were calculated by a model. RESULTS: The number of people over 65 in the Netherlands increases by 34% between 2010 and 2020. The registrations by general practitioners show an increase of 43% of patients with eye conditions. Modelling of the new treatment methods demonstrates a threefold increase of the number of treatments. Finally, it appears that the number of blind and visually impaired people increases by 20%. The prevalence of visual impairment is the highest in elderly in health-care institutions, mentally handicapped and elderly living independently. CONCLUSION: The demand for eye-care services will increase by 200-300% between 2010 and 2020. The most important cause for this is the new treatment for 'wet' AMD and macular oedema using intravitreal angiogenesis inhibitors. The capacity of eye care services needs to be increased, partly by a redistribution of tasks between different professional groups within the eye care sector. Routine vision screening of elderly in care institutions and people with a mental handicap can reduce the number of Dutch people with avoidable visual impairment. For elderly living independently, provision of information and selective screening is indicated.
Authors: Jessica Cao; Brittany Chang-Kit; Glen Katsnelson; Parsa Merhraban Far; Elizabeth Uleryk; Adeteju Ogunbameru; Rafael N Miranda; Tina Felfeli Journal: Diagn Progn Res Date: 2022-07-14
Authors: Wouter Schakel; Christina Bode; Hilde P A van der Aa; Carel T J Hulshof; Judith E Bosmans; Gerardus H M B van Rens; Ruth M A van Nispen Journal: BMJ Open Date: 2017-08-03 Impact factor: 2.692
Authors: Ellen Bernadette Maria Elsman; Ruth Marie Antoinette van Nispen; Gerardus Hermanus Maria Bartholomeus van Rens Journal: Health Qual Life Outcomes Date: 2017-05-11 Impact factor: 3.186
Authors: Raba Thapa; Sanyam Bajimaya; Govinda Paudyal; Shankar Khanal; Stevie Tan; Suman S Thapa; G H M B van Rens Journal: BMC Ophthalmol Date: 2018-02-13 Impact factor: 2.209
Authors: Sophie Lemmens; João Barbosa Breda; Karel Van Keer; Tine Jacobs; Ruben Van Landeghem; Patrick De Boever; Ingeborg Stalmans Journal: J Ophthalmol Date: 2020-11-07 Impact factor: 1.909
Authors: Hilde Pa van der Aa; Ger Hmb van Rens; Frank D Verbraak; Machteld Bosscha; Hannie C Comijs; Ruth Ma van Nispen Journal: Ophthalmic Physiol Opt Date: 2021-05-29 Impact factor: 3.117
Authors: Hilde L Vreeken; Ger H M B van Rens; Sophia E Kramer; Dirk L Knol; Joost M Festen; Ruth M A van Nispen Journal: BMC Geriatr Date: 2013-08-13 Impact factor: 3.921
Authors: Linda Rainey; Ellen Bernadette Maria Elsman; Ruth Marie Antoinette van Nispen; Lisette Michelle van Leeuwen; Gerardus Hermanus Maria Bartholomeus van Rens Journal: Qual Life Res Date: 2016-04-13 Impact factor: 4.147
Authors: Ruth van Nispen; Hilde van der Aa; Frank Timmermans; Nikki Meijer; Nicole Koster; Jos de Blok; Jan Keunen; Ger van Rens Journal: Acta Ophthalmol Date: 2018-10-27 Impact factor: 3.761
Authors: I M Maaswinkel; H P A van der Aa; G H M B van Rens; A T F Beekman; J W R Twisk; R M A van Nispen Journal: BMC Psychiatry Date: 2020-09-24 Impact factor: 3.630